Boston Partners lowered its position in shares of Amdocs Limited (NASDAQ:DOX) by 4.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 7,111,712 shares of the technology company’s stock after selling 352,752 shares during the period. Boston Partners’ holdings in Amdocs Limited were worth $458,421,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Robecosam AG acquired a new position in Amdocs Limited during the first quarter worth approximately $114,000. Creative Planning increased its position in Amdocs Limited by 62.7% in the first quarter. Creative Planning now owns 2,198 shares of the technology company’s stock worth $134,000 after buying an additional 847 shares during the period. Northwestern Mutual Wealth Management Co. increased its position in Amdocs Limited by 30.6% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,969 shares of the technology company’s stock worth $181,000 after buying an additional 696 shares during the period. Atria Investments LLC acquired a new position in Amdocs Limited during the second quarter worth approximately $218,000. Finally, HighTower Advisors LLC acquired a new position in Amdocs Limited during the first quarter worth approximately $220,000. 89.97% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Limited (DOX) opened at 65.51 on Thursday. Amdocs Limited has a 12 month low of $54.91 and a 12 month high of $67.98. The stock has a 50 day moving average of $65.42 and a 200-day moving average of $62.69. The stock has a market cap of $9.56 billion, a P/E ratio of 22.76 and a beta of 0.54.

Amdocs Limited (NASDAQ:DOX) last announced its quarterly earnings results on Wednesday, August 2nd. The technology company reported $1.02 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.96 by $0.06. The company had revenue of $967 million for the quarter, compared to analyst estimates of $967.04 million. Amdocs Limited had a net margin of 11.11% and a return on equity of 14.73%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.90 earnings per share. On average, equities analysts forecast that Amdocs Limited will post $3.81 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 20th. Stockholders of record on Friday, September 29th will be given a dividend of $0.22 per share. The ex-dividend date is Thursday, September 28th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.34%. Amdocs Limited’s dividend payout ratio (DPR) is presently 30.66%.

COPYRIGHT VIOLATION NOTICE: “Boston Partners Reduces Position in Amdocs Limited (DOX)” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/10/boston-partners-reduces-position-in-amdocs-limited-dox.html.

A number of research analysts have recently issued reports on the stock. Barclays PLC reaffirmed a “hold” rating and issued a $68.00 price objective on shares of Amdocs Limited in a research report on Friday, August 4th. Zacks Investment Research downgraded shares of Amdocs Limited from a “buy” rating to a “hold” rating in a research report on Tuesday. Stifel Nicolaus reaffirmed a “buy” rating and issued a $68.00 price objective on shares of Amdocs Limited in a research report on Wednesday, June 28th. BidaskClub downgraded shares of Amdocs Limited from a “hold” rating to a “sell” rating in a research report on Tuesday. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $59.00 price objective on shares of Amdocs Limited in a research report on Friday, June 16th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $67.63.

About Amdocs Limited

Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).

Institutional Ownership by Quarter for Amdocs Limited (NASDAQ:DOX)

Receive News & Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related companies with MarketBeat.com's FREE daily email newsletter.